Amit P Amin1, Tracy Y Wang2, Lisa McCoy2, Richard G Bach1, Mark B Effron2, Eric D Peterson3, David J Cohen4. 1. Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri; Barnes-Jewish Hospital, St. Louis, Missouri. 2. Lilly Research Laboratories, Indianapolis, Indiana. 3. Division of Cardiology, Duke University Medical Center, Durham, North Carolina. 4. Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri. Electronic address: dcohen@saint-lukes.org.
Abstract
BACKGROUND: Prolonged dual antiplatelet therapy (DAPT) is recommended after an acute myocardial infarction (AMI) to reduce ischemic events but is associated with increased rates of major and minor bleeding. OBJECTIVES: This study sought to determine the incidence of post-percutaneous coronary intervention (PCI) bleeding that occurs on contemporary DAPT and its impact on quality of life (QOL). METHODS: We studied 9,290 AMI patients treated with PCI and discharged alive between April 2010 and September 2012. Post-discharge bleeding was categorized according to the Bleeding Academic Research Consortium (BARC) definition. The primary outcome was the 6-month Euro QOL-5 Dimension (EQ-5D) index score (a measure of health utility); a secondary outcome was the EQ-5D visual analog scale (VAS) at 6 months. RESULTS: Of the 9,290 patients with AMI, bleeding events occurred as follows: any BARC bleeding: 24.2%; BARC 1: 9.1%; BARC 2: 13.8%; BARC 3: 1.1%; BARC 4: 0.03%; and BARC 5: 0%. Those who experienced any BARC bleeding had lower scores across all 5 EQ-5D domains (mobility, self-care, usual activities, pain, and anxiety), as well as lower EQ-5D VAS and EQ-5D index scores. After clinical risk adjustment, any BARC bleeding was independently associated with 6-month EQ-5D index score (p < 0.0001) and lower QOL (p < 0.001). Both the EQ-5D index and the VAS score declined in a stepwise fashion with increasing BARC severity. CONCLUSIONS: Among patients undergoing PCI for AMI, bleeding during follow-up was associated with worse 6-month utility and QOL. Although even minor bleeding was associated with impaired health status and QOL, the degree of impairment increased in a stepwise fashion with bleeding severity.
BACKGROUND: Prolonged dual antiplatelet therapy (DAPT) is recommended after an acute myocardial infarction (AMI) to reduce ischemic events but is associated with increased rates of major and minor bleeding. OBJECTIVES: This study sought to determine the incidence of post-percutaneous coronary intervention (PCI) bleeding that occurs on contemporary DAPT and its impact on quality of life (QOL). METHODS: We studied 9,290 AMI patients treated with PCI and discharged alive between April 2010 and September 2012. Post-discharge bleeding was categorized according to the Bleeding Academic Research Consortium (BARC) definition. The primary outcome was the 6-month Euro QOL-5 Dimension (EQ-5D) index score (a measure of health utility); a secondary outcome was the EQ-5D visual analog scale (VAS) at 6 months. RESULTS: Of the 9,290 patients with AMI, bleeding events occurred as follows: any BARC bleeding: 24.2%; BARC 1: 9.1%; BARC 2: 13.8%; BARC 3: 1.1%; BARC 4: 0.03%; and BARC 5: 0%. Those who experienced any BARC bleeding had lower scores across all 5 EQ-5D domains (mobility, self-care, usual activities, pain, and anxiety), as well as lower EQ-5D VAS and EQ-5D index scores. After clinical risk adjustment, any BARC bleeding was independently associated with 6-month EQ-5D index score (p < 0.0001) and lower QOL (p < 0.001). Both the EQ-5D index and the VAS score declined in a stepwise fashion with increasing BARC severity. CONCLUSIONS: Among patients undergoing PCI for AMI, bleeding during follow-up was associated with worse 6-month utility and QOL. Although even minor bleeding was associated with impaired health status and QOL, the degree of impairment increased in a stepwise fashion with bleeding severity.
Authors: Dragan M Matic; Dejan G Milasinovic; Milika R Asanin; Igor B Mrdovic; Jelena M Marinkovic; Nikola I Kocev; Marija M Marjanovic; Nebojsa M Antonijevic; Vladan D Vukcevic; Lidija Z Savic; Milorad N Zivkovic; Zlatko H Mehmedbegovic; Vladimir M Dedovic; Goran R Stankovic Journal: Heart Date: 2013-10-31 Impact factor: 5.994
Authors: Giulio G Stefanini; George C M Siontis; Davide Cao; Dik Heg; Peter Jüni; Stephan Windecker Journal: J Am Coll Cardiol Date: 2014-09-02 Impact factor: 24.094
Authors: Gjin Ndrepepa; Tibor Schuster; Martin Hadamitzky; Robert A Byrne; Julinda Mehilli; Franz-Josef Neumann; Gert Richardt; Stefanie Schulz; Karl-Ludwig Laugwitz; Steffen Massberg; Albert Schömig; Adnan Kastrati Journal: Circulation Date: 2012-02-17 Impact factor: 29.690
Authors: Chee Tang Chin; Anita Y Chen; Tracy Y Wang; Karen P Alexander; Robin Mathews; John S Rumsfeld; Christopher P Cannon; Gregg C Fonarow; Eric D Peterson; Matthew T Roe Journal: Am Heart J Date: 2011-01 Impact factor: 4.749
Authors: Suzanne V Arnold; Paul S Chan; Philip G Jones; Carole Decker; Donna M Buchanan; Harlan M Krumholz; P Michael Ho; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2011-07
Authors: Wouter J Kikkert; Nan van Geloven; Mariet H van der Laan; Marije M Vis; Jan Baan; Karel T Koch; Ron J Peters; Robbert J de Winter; Jan J Piek; Jan G P Tijssen; José P S Henriques Journal: J Am Coll Cardiol Date: 2014-03-19 Impact factor: 24.094
Authors: Alexander C Fanaroff; Vic Hasselblad; Matthew T Roe; Deepak L Bhatt; Stefan K James; Ph Gabriel Steg; C Michael Gibson; E Magnus Ohman Journal: Int J Cardiol Date: 2017-03-14 Impact factor: 4.164
Authors: Praneet K Sharma; Adnan K Chhatriwalla; David J Cohen; Jae-Sik Jang; Paramdeep Baweja; Kensey Gosch; Philip Jones; Richard G Bach; Suzanne V Arnold; John A Spertus Journal: Catheter Cardiovasc Interv Date: 2016-04-01 Impact factor: 2.692
Authors: Simone Biscaglia; Elisabetta Tonet; Rita Pavasini; Matteo Serenelli; Giulia Bugani; Paolo Cimaglia; Francesco Gallo; Giosafat Spitaleri; Annamaria Del Franco; Giorgio Aquila; Francesco Vieceli Dalla Sega; Matteo Tebaldi; Carlo Tumscitz; Roberto Ferrari; Gianluca Campo Journal: PLoS One Date: 2017-08-23 Impact factor: 3.240
Authors: Simone A Huygens; Isaac Corro Ramos; Carlijn V C Bouten; Jolanda Kluin; Shih Ting Chiu; Gary L Grunkemeier; Johanna J M Takkenberg; Maureen P M H Rutten-van Mölken Journal: Eur J Health Econ Date: 2020-01-25
Authors: Brett Doble; Maria Pufulete; Jessica M Harris; Tom Johnson; Daniel Lasserson; Barnaby C Reeves; Sarah Wordsworth Journal: Health Qual Life Outcomes Date: 2018-09-20 Impact factor: 3.186
Authors: Kaijun Wang; Haiyan Li; Winghan J Kwong; Elliott M Antman; Christian T Ruff; Robert P Giugliano; David J Cohen; Elizabeth A Magnuson Journal: J Am Heart Assoc Date: 2017-08-11 Impact factor: 5.501